| Dataset | DrugBank Drug Targets |
| Category | physical interactions |
| Type | drug |
| Description | An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. (Chemical Entities of Biological Interest Ontology, CHEBI_4717) |
| External Link | http://www.drugbank.ca/drugs/DB00450 |
| Similar Terms | |
| Downloads & Tools |
2 interacting proteins for the Droperidol drug from the curated DrugBank Drug Targets dataset.
